Six-year results from RELEVANCE: Lenalidomide plus rituximab (R(2)) versus rituximab-chemotherapy followed by rituximab maintenance in untreated advanced follicular lymphoma Journal Article

   

Authors:	Morschhauser, F.; Nastoupil, L.; Feugier, P.; Schiano de Colella, J. M.; Tilly, H.; Palomba, M. L.; Bachy, E.; Fruchart, C.; Libby, E. N.; Casasnovas, R. O.; Flinn, I. W.; Haioun, C.; Maisonneuve, H.; Ysebaert, L.; Bartlett, N. L.; Bouabdallah, K.; Brice, P.; Ribrag, V.; Le Gouill, Steven; Daguindau, Nicolas; Guidez, , S.; Pica, G. M.; García-Sancho, A. M.; López-Guillermo, A.; Larouche, J. F.; Ando, K.; Gomes da Silva, M.; André, M.; Kalung, W.; Sehn, L. H.; Izutsu, K.; Cartron, G.; Gkasiamis, A.; Crowe, R.; Zerri, L.; Fowler, N. H.; Salles, G.
Article Title:	Six-year results from RELEVANCE: Lenalidomide plus rituximab (R(2)) versus rituximab-chemotherapy followed by rituximab maintenance in untreated advanced follicular lymphoma
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	28
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-10-01
Start Page:	3239
End Page:	3245
Language:	English
DOI:	10.1200/jco.22.00843
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
PMCID:	PMC9553375
PUBMED:	35947804
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=159384902&site=ehost-live&scope=site&custid=s2915669
Notes:	Accession Number: 159384902 -- Entry Date: 20221001 -- Revision Date: 20220930 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198694